Related Experiment Videos
Aortocoronary bypass grafting with expanded polytetrafluoroethylene: 12-year patency
A J McLarty1, M R Phillips, D R Holmes
1Section of Cardiovascular Surgery, Mayo Clinic, Rochester, Minnesota 55905, USA.
Insights
Expanded polytetrafluoroethylene grafts offer long-term patency for coronary artery bypass surgery when autologous conduits are unavailable. This case demonstrates a 12-year documented patency, challenging previous assumptions about prosthetic graft durability.
Area of Science:
- Cardiovascular Surgery
- Biomaterials Science
- Vascular Grafting
Background:
- Prosthetic coronary artery bypass conduits have limited use due to high thrombosis rates compared to autologous grafts.
- Low medium-term patency restricts prosthetic graft use to specific patient groups or emergencies.
Observation:
- A patient received a coronary artery bypass graft using expanded polytetrafluoroethylene (ePTFE).
Findings:
- The ePTFE graft demonstrated documented patency 12 years post-operation.
- This long-term patency challenges the conventional understanding of prosthetic conduit limitations.
Implications:
- Expanded polytetrafluoroethylene may be a viable option for long-term coronary artery bypass grafting.
- Further research into prosthetic conduit durability could expand treatment options for coronary artery disease.
- This finding may encourage re-evaluation of prosthetic graft use in specific clinical scenarios.
Abstract:
Prosthetic coronary artery bypass conduits are rarely used because the rate of thrombosis is inherently higher than that with autologous conduits. The low medium-term patency rates of prosthetic grafts have restricted their use primarily to patients with inadequate autologous conduits or to selected emergencies. We describe a patient treated with expanded polytetrafluoroethylene who had documented patency 12 years after the operation.